LClose 4.47 Price 4.47
Change 0.00 (0.00%) Low 4.47
High 4.47 EPS 0.14
52WkHigh 5.18 52WkLow 2.90
50d Mov Avg 4.63 200d Mov Avg 4.22
AvgDlyVol 324.46K 3MthChg 0.43 (10.64%)
6MthChg 0.57 (14.62%) 12MthChg 1.40 (45.60%)
Beta 0.1330416 Risk Factor 0.001799315
PE 32.93 Shares Outs. 1.73B
Div. Yield 6.71 Market Cap 7.71B
Volume 40.84K # Of Trades 3
Trades Value 183.30K
Sector Pharmaceuticals
Company Profile

May & Baker Nigeria Plc engages in the manufacture, sale, and distribution of human pharmaceuticals and vaccines, and food and beverage products in Nigeria. Its product line includes cough and cold preparations, anti histamines, sulphonamides, anti-amoebicides, anti-malarials, anti-dibiaetics, analgesics, anti-hypertensives, and antibiotics. The company also offers noodles under the Mimee brand name; and water under the Lily brand name. May & Baker Nigeria Plc was founded in 1944 and is headquartered in Lagos, Nigeria.

Website:	www.may-baker.com
Founded in:	1944

Income statement

Statement of Comprehensive Income as at

Name Amount
Revenue 8,552,163.00
Profit before taxation 817,912.00
Taxation -475,226.00
Profit/(loss) after tax 342,686.00
Transfer to revenue reserve 342,686.00
Profit attributable to:
Owners of the company 342,686.00
Non-controlling interest
Earnings per 50k share (k) 35.00
Net assets per 50k share (k) 4.00
Most Recent Financial Statements for MAY & BAKER NIGERIA PLC.
Board of directors
Name Title
Theophilus Danjuma Non-Executive Chairman
Nnamdi Okafor Managing Director/Chief Executive Officer, Executive Director
Ayodeji Aboderin Financial Controller/Chief Financial Officer
Ezekiel Ibidapo Pharmaceutical Manufacturing Operations, Executive Director
Valentine Okelu General Manager/Head, Foods Division
Chukutem Chukuka Head, Pharma Sales and Marketing
Gladys Umoh Head, Human Capital Development
Edudie Abebe Non-Executive Director
Adebayo Adeleke Non-Executive Director
Ishaya Dankaro Non-Executive Director
Gloria Odumodu Non-Executive Director